Celgene Corporation (CELG)

Trade CELG now with
12/13/2018 7:30:47 AM Jeff Jonker Joins Ambys Medicines As President And CEO
12/3/2018 7:34:52 PM Celgene Announces Initial Data From Phase 1/2 Evolve Trial With Anti-BCMA CAR T Therapy JCARH125 In Relapsed/RMM
12/2/2018 7:36:40 PM Celgene Announces Results Of AUGMENT Evaluating REVLIMID In Combination With Rituximab In Relapsed/RIL
12/2/2018 7:33:57 PM Bluebird Bio, Celgene Present Initial Data From Phase 1 Study Of Anti-BCMA CAR T Cell Therapy Bb21217 In Relapsed/RMM
12/2/2018 5:40:17 PM Celgene And Acceleron Pharma Announce Results Of Phase 3 MEDALIST Trial Evaluating Luspatercept In Patients With MDS
12/2/2018 10:49:38 AM Celgene Announces Initial Phase 1/2 Liso-cel Data In Patients With Relapsed/Refractory CLL
11/27/2018 7:32:55 AM Celgene And Bluebird Bio Complete Enrollment For KarMMa Pivotal Tudy Of Bb2121
11/14/2018 8:01:16 AM Lyfebulb Partners With Celgene To Inspire Patient-Driven Innovation In Management Of Multiple Sclerosis
10/25/2018 7:43:22 AM Celgene Corporation (CELG) Has Raised Its FY18 EPS Estimate To 8.75 - 8.80 From 8.70 - 8.75
10/25/2018 7:42:48 AM Celgene Corporation (CELG) Has Raised Its FY18 Revenue Estimate To $15.2 Bln From $15.0 Bln
10/25/2018 7:32:57 AM Celgene Q3 EPS $1.50 Vs $1.21 Last Year
10/22/2018 4:34:39 PM Celgene Appoints Alise Reicin As President, Global Clinical Development
10/22/2018 7:31:56 AM Celgene Presents First Results Of New Data Of ABRAXANE In Combination With Atezolizumab At ESMO 2018
10/11/2018 1:40:35 AM Evotec To Receive $6 Mln Payment From Celgene
10/10/2018 7:30:51 AM Celgene Reports New Analyses From Pivotal Phase 3 Trials Of Oral Ozanimod To Be Presented At ECTRIMS 2018